Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giles Walters

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Annals of the Rheumatic Diseases|January 7, 2019
Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trialRachel B Jones, Thomas F Hiemstra, Jose Ballarin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 18, 2013
Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysisBhadran Bose, Sunil V Badve, Swapnil S Hiremath, et al.
The New England Journal of Medicine|June 25, 2020
Effects of Allopurinol on the Progression of Chronic Kidney DiseaseSunil V Badve, Elaine M Pascoe, Anushree Tiku, et al.
Annals of the Rheumatic Diseases|March 23, 2023
Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trialRona M Smith, Rachel B Jones, Ulrich Specks, et al.
Annals of the Rheumatic Diseases|June 26, 2020
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitisRona M Smith, Rachel Bronwen Jones, Ulrich Specks, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Annals of the Rheumatic Diseases|January 7, 2019
Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trialRachel B Jones, Thomas F Hiemstra, Jose Ballarin, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 18, 2013
Effects of uric acid-lowering therapy on renal outcomes: a systematic review and meta-analysisBhadran Bose, Sunil V Badve, Swapnil S Hiremath, et al.
The New England Journal of Medicine|June 25, 2020
Effects of Allopurinol on the Progression of Chronic Kidney DiseaseSunil V Badve, Elaine M Pascoe, Anushree Tiku, et al.
Annals of the Rheumatic Diseases|March 23, 2023
Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trialRona M Smith, Rachel B Jones, Ulrich Specks, et al.
Annals of the Rheumatic Diseases|June 26, 2020
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitisRona M Smith, Rachel Bronwen Jones, Ulrich Specks, et al.
Pageof 3